Barium
Active ingredient
Sold as BARICLEAR 94.6% W/WGRANULE… · BARICLEAR 100% W/V…
- Drug class
- -
- Availability
- See label
- Markets covered
- 1
- Products on record
- 3
Overview
Barium is an active pharmaceutical ingredient. The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 3 | March 13, 2026 |
GBUnited Kingdom· MHRA
3 products
Uses
BariClear® 100% w/v Suspension is an X-ray contrast medium for use in the radiological examination of the gastrointestinal tract.
How to take
Oral or by enema in accordance with the parts to be examined and examination methods Adults and Elderly Part of GI Tract Method Volume (ml) Concentration (% w/v) Oesophagus Oral 10-150 50-100 Stomach & Duodenum Oral, Double- Contrast, Distension Filling & Relief 10-300 30-100 Small Intestine Oral 100-300 30-100 Colon Enema 200-2000 20-100 Children As for adults but in proportion to body weight.
Infants As for adults but in proportion to body weight.
This is not medical advice. Consult a qualified healthcare professional.
Side effects & warnings
May cause constipation, transient diarrhoea, abdominal pain, anal pain and bleeding.
BariClear® 100% w/v Suspension should be used with great caution in:
Oral use: Suspected or known fistula in digestive organs. Stricture or signs suggesting obstruction. Suffering from extreme exhaustion.
Enema use:
Suspected or known fistula in digestive organs. g. appendicitis, diverticulitis, ulcerative colitis, invagination tumour, parasitic disease). Water and laxatives should be given to patients after investigation to prevent constipation.
This is not medical advice. Consult a qualified healthcare professional.
Who should not take it
Oral Use:
Suspected perforation of intestinal organs: Haemorrhage in digestive organs.
Enema Use:
Suspected perforation of intestinal organs: Haemorrhage in digestive organs: Extreme exhaustion.
This is not medical advice. Consult a qualified healthcare professional.
Brands in United Kingdom (2)
Sources & citations
- [1]MHRA (UK) · PL556440001 · revised September 19, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.